LeonaBio (LONA) Amortizatization of Intangibles (2019 - 2026)
LeonaBio (LONA) reported Amortizatization of Intangibles of $74000.0 for Q1 2026, up 13.85% year-over-year from $65000.0 in Q1 2025, and up 10.45% on a QoQ basis from $67000.0 in Q4 2025.
LeonaBio (LONA) has 8 years of Amortizatization of Intangibles data on file, last reported at $74000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 13.85% year-over-year to $74000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $338000.0 (up 745.0% YoY) and the FY2025 annual result came in at $329000.0, up 36.51% from the prior year.
- Amortizatization of Intangibles climbed to $74000.0 in Q1 2026 per LONA's latest filing, from $67000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $686000.0 in Q2 2023 and bottomed at -$917000.0 in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $67000.0 (2025), against an average of $75294.1.
- Peak annual rise in Amortizatization of Intangibles reached 1359.57% in 2023, while the deepest fall reached 442.16% in 2023.
- Tracing LONA's Amortizatization of Intangibles over 5 years: stood at $268000.0 in 2022, then slumped by 442.16% to -$917000.0 in 2023, then soared by 106.87% to $63000.0 in 2024, then increased by 6.35% to $67000.0 in 2025, then advanced by 10.45% to $74000.0 in 2026.
- Per Business Quant, the three latest LONA Amortizatization of Intangibles figures stand at $74000.0 (Q1 2026), $67000.0 (Q4 2025), and $70000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | 74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | -253,000.00 |
| Sep 30, 2024 | -253,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | -917,000.00 |
| Dec 31, 2023 | -917,000.00 |
| Sep 30, 2023 | 394,000.00 |
| Sep 30, 2023 | 394,000.00 |
| Jun 30, 2023 | 686,000.00 |
| Jun 30, 2023 | 686,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 268,000.00 |
| Dec 31, 2022 | 268,000.00 |
| Sep 30, 2022 | 62,000.00 |
| Sep 30, 2022 | 62,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | 502,000.00 |
| Dec 31, 2021 | 502,000.00 |
| Sep 30, 2021 | -415,000.00 |
| Sep 30, 2021 | -415,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Mar 31, 2021 | 28,000.00 |
| Mar 31, 2021 | 28,000.00 |
| Dec 31, 2020 | -165,000.00 |
| Dec 31, 2020 | -165,000.00 |
| Mar 31, 2020 | 172,000.00 |
| Mar 31, 2020 | 172,000.00 |
| Dec 31, 2019 | 83,000.00 |
| Dec 31, 2019 | 83,000.00 |